AbbVie's Allergan, Molecular Partners hit by FDA eye drug rejection DIY vaccine maker aims to beat pharma to a COVID-19 shot—and he'll start by injecting himself EMA picks WHO's Cooke to replace Rasi as executive director Sponsored: Rise in Targeted Therapies Drives Need for Flexible Small-Volume Manufacturing Awaiting IPO, Poseida Therapeutics nips in a quick $110M series D Natural killer biotech Artiva launches with $78M, industry veterans Medtronic's brain-reading stimulator nets FDA approval Chutes & Ladders—Allergan ex-CEO Saunders takes board seat at BridgeBio FiercePharmaAsia—WuXi NextCODE rebrand; remdesivir generic prices; Sinopharm COVID vax phase 3 Featured Story | Friday, June 26, 2020 When you spend $63 billion on a company, your hope is that investment will come back; sometimes, however, you get hit with problems. read more |
| |
|---|
|
Top Stories Friday, June 26, 2020 While governments inject cash into a COVID shot, one DIY vaccine maker thinks he can beat biopharma to the punch—and he'll start by injecting himself. Nevermind that companies like Moderna and AstraZeneca are racing vaccine candidates into and through the clinic at unprecedented speeds with plans to bring vaccines to Americans this year. read more Friday, June 26, 2020 The European Medicines Agency management board has nominated Emer Cook to be the next executive director of the agency. Cooke, who works at the World Health Organization, will replace Guido Rasi later in the year if she comes through the remaining steps in the hiring process. read more Monday, June 22, 2020 Innovative therapies target small numbers of patients. Smaller demand for a therapy, means that sterile injectable manufacturing needs to accommodate smaller batch sizes and more flexibility. read more Friday, June 26, 2020 Last week, CAR-T biotech Poseida Therapeutics said it was gunning for another IPO attempt a year after ditching it in favor of a new funding round led by Novartis. read more Friday, June 26, 2020 A new San Diego biotech has come out of the shadows with a meaty $78 million series A and a next-gen immuno-oncology platform and plans to start human testing this year. read more Thursday, June 25, 2020 The FDA has approved Medtronic’s latest deep-brain stimulation implant featuring the ability to read, capture and transmit a patient’s brain signals during therapy. read more Friday, June 26, 2020 BridgeBio taps former Allergan CEO Saunders for board; Sangamo lets R&D head Woolfson walk; Sygnature nabs Eurofins exec Overton. read more Friday, June 26, 2020 WuXi NextCODE changes its name to Genuity Science without its Shanghai operations. Cipla and Hetero Labs have launched generic remdesivir in India at about $70 a vial. China's Sinopharm is kick-starting a phase 3 trial of its COVID-19 vaccine in the United Arab Emirates. And more. read more Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy University of Florida precision medicine leaders highlight current knowledge and trends to advance the future of health care in this quarterly webinar series. Register today. |
| |
|---|
|
Resources Sponsored by: Systech Get an inside look… Merck shares its next-generation approach to supply chain protection with new digital platforms, including Blockchain. Presented by: Cytiva On-demand video: fuel gene therapy development and production with modern AAV workflows. Sponsored by: Automation Anywhere Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense. Sponsored by: Cenduit Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 